Cronos: What’s the Word on Wall Street?

405

Cronos Group ( CRON ) reported its second-quarter results last month. Despite better-than-expected sales, the company’s second-quarter losses widened. Cronos was also in the news last month due to its acquisition of the hemp-based CBD (cannabidiol) platform from Redwood Holding, including the Lord Jones premium brand.
Analysts’ activity after CRON’s Q2 results Following its second-quarter results, Canaccord Genuity upgraded its rating for Cronos to “hold” from “sell” on August 9.

Ga naar Bron